Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?

Translational research: Ready for patient selection?

Date

17 Oct 2020

Session

Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?

Topics

Tumour Site

Melanoma

Presenters

Christian Blank

Authors

C.U. Blank

Author affiliations

Medical Oncology Dept, NKI-AVL - Netherlands Cancer Institute/Antoni van Leeuwenhoek Hospital, 1066 CX - Amsterdam/NL

Resources

Login to get immediate access to this content.

If you do not have an ESMO account, please create one for free.

Login

Resources from the same session

17 Oct 2020

Controversies in the surgical management of stage III melanoma

Presenter: Merrick Ross

Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?

Resources:

Slides

Webcast

17 Oct 2020

Adjuvant and neo-adjuvant therapy

Presenter: Georgina Long

Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?

Resources:

Slides

Webcast

17 Oct 2020

Q&A and live discussion

Presenter: Christian Blank

Session: Adjuvant and neo-adjuvant therapy for stage III melanoma: Who, what and when?

Resources:

Webcast